Choate Investment Advisors Exact Sciences Corp Transaction History

Choate Investment Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$57.56 - $82.54 $176,709 - $253,397	-3,070 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$72.5 - $100.68 $1,957 - $2,718	-27 Reduced 0.87%	3,070 $239,000
Q3 2021 Nov 04, 2021	BUY	$90.24 - $124.05 $32,937 - $45,278	365 Added 13.36%	3,097 $296,000
Q2 2021 Jul 30, 2021	BUY	$93.66 - $139.27 $8,335 - $12,395	89 Added 3.37%	2,732 $340,000
Q1 2021 May 07, 2021	SELL	$116.57 - $155.01 $20,050 - $26,661	-172 Reduced 6.11%	2,643 $348,000
Q4 2020 Feb 08, 2021	BUY	$99.61 - $142.12 $19,922 - $28,424	200 Added 7.65%	2,815 $373,000
Q2 2020 Jul 23, 2020	BUY	$55.75 - $92.75 $145,786 - $242,541	2,615 New	2,615 $227,000

671

163M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $8.73B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Choate Investment Advisors, based on Form 13F filings with the SEC.

Stay updated on Choate Investment Advisors with notifications on news.